We thank you for your interest in our recent systematic review and share your view that the efficacy results of thrombolysis and mechanical thrombectomy in infective endocarditis should be read with caution, because of the low quality of available evidence, as shown in our review.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Stroke and Cerebrovascular Diseases
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Neurological Complications of infective endocarditis.Curr Neurol Neurosci Rep. 2019; 19: 23
Published online: March 20, 2020
© 2020 Elsevier Inc. All rights reserved.
ScienceDirectAccess this article on ScienceDirect
- Safety and Efficacy of Thrombolysis and Mechanical Thrombectomy in Infective EndocarditisJournal of Stroke and Cerebrovascular DiseasesVol. 29Issue 6
- PreviewWe read with much interest the article “Acute Ischemic Stroke Treatment in Infective Endocarditis: Systemic Review” by Bettencourt et al, published in your esteemed journal. Authors have reviewed 37 articles including 52 patients. Sixteen of whom received IV thrombolysis, 22 received mechanical thrombectomy, 11 received combined treatment. The authors stated that the quality of the articles were low. And have concluded that the risk of intracerebral hemorrhage was 4 times higher in the group treated with IV thrombolysis comparing to the group treated with thrombectomy.